Arsenal Capital Partners beefs up management with new appointment

New York-based private equity firm Arsenal Capital Partners has named Frank Scrudato as chief financial officer and chief compliance officer. Prior to joining Arsenal, Scrudato worked at Bruckmann, Rosser, Sherrill & Co. where he served as CFO and principal.


NEW YORK, February 13, 2014 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market specialty industrial and healthcare companies, announced today the appointment of Frank Scrudato as Chief Financial Officer and Chief Compliance Officer.
Mr. Scrudato was formerly Chief Financial Officer and Principal of Bruckmann, Rosser, Sherrill & Co. (“BRS”). Prior to BRS, he was a Director in the Transaction Services practices of KPMG and Arthur Andersen. Mr. Scrudato also worked as the Director of Corporate Development for Asbury Automotive Group. Mr. Scrudato received his BS from Rutgers University.
Jeffrey Kovach, co-founder and Partner of Arsenal, said, “Frank is a key addition to Arsenal’s team who brings strong capabilities in managing the financial, operational and administrative aspects of a private equity firm. Frank’s experience in middle market private equity will enable Arsenal to maintain its high compliance standards and to continue to adapt to the additional regulatory focus on our industry. His leadership ability and personality are an excellent fit with Arsenal’s culture and values and we look forward to Frank playing a significant role as we continue to advance our firm.”
Pilar Lorente, Arsenal’s Chief Financial Officer since 2006, will continue to assist the firm on an ongoing basis with finance and compliance projects. In addition, Ms. Lorente will advise small businesses and investment firms on finance and compliance issues. “In her seven years at Arsenal Capital, Pilar has helped to elevate the firm’s finance, compliance and investor reporting functions,” said Mr. Kovach.
About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. Arsenal targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities.
Arsenal currently has $1.7 billion of committed equity capital. For additional information on Arsenal Capital Partners, please visit